Junrungsee Sunhawit, Vipudhamorn Witcha, Lapisatepun Worakitti, Thepbunchonchai Asara, Chotirosniramit Anon, Lapisatepun Warangkana, Ko-Iam Wasana
Division of Hepatobiliary Pancreatic Surgery, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Clinical Surgical Research Center, Chiang Mai University, Chiang Mai, Thailand.
Division of Colorectal Surgery, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Surgery. 2025 Sep;185:109351. doi: 10.1016/j.surg.2025.109351. Epub 2025 Apr 9.
Posthepatectomy liver failure is a serious clinical issue with high mortality, similar in pathophysiology to small-for-size syndrome seen in liver transplantation. This study evaluates the efficacy of splenic artery ligation in reducing posthepatectomy liver failure in patients with portal venous pressure >15 mm Hg after hepatectomy.
This single-center, randomized controlled trial was conducted from May 2019 to November 2023. Eligible participants were patients scheduled for open hepatectomy for any indication. Patients with a portal venous pressure >15 mm Hg were randomized into splenic artery ligation and control groups in a 1:1 ratio. The primary outcomes were posthepatectomy liver failure grades B and C (International Study group of Liver Surgery criteria), and secondary outcomes included 90-day mortality, comprehensive complication index, and ascites volume.
The study was terminated early, before reaching the calculated sample size, because the primary outcome in the intervention group demonstrated statistically significant results. Of the 92 patients, 36 had elevated portal venous pressure, which was associated with greater rates of posthepatectomy liver failure grades B and C (41.67% vs 3.57%, P < .001), increased ascites volume (5,340 mL vs 1,055 mL, P < .001), and a greater comprehensive complication index (20.90 vs 8.70, P < .001). In the randomized subset, splenic artery ligation significantly reduced portal venous pressure and the portal venous pressure-central venous pressure gradient compared with both presplenic artery ligation values and the control group and significantly lowered the incidence of posthepatectomy liver failure grades B and C (16.67% vs 66.67%, P = .006), comprehensive complication index (8.70 vs 20.90, P = .034). Splenic artery ligation was identified as an independent factor in reducing posthepatectomy liver failure (adjusted relative risk, 0.29).
Splenic artery ligation is effective in reducing posthepatectomy liver failure in patients with high portal venous pressure after hepatectomy.
肝切除术后肝衰竭是一个严重的临床问题,死亡率高,其病理生理学与肝移植中所见的小肝综合征相似。本研究评估脾动脉结扎术在降低肝切除术后门静脉压力>15 mmHg患者肝切除术后肝衰竭发生率方面的疗效。
本单中心随机对照试验于2019年5月至2023年11月进行。符合条件的参与者为因任何适应症计划接受开放性肝切除术的患者。门静脉压力>15 mmHg的患者按1:1比例随机分为脾动脉结扎组和对照组。主要结局为肝切除术后B级和C级肝衰竭(国际肝外科研究组标准),次要结局包括90天死亡率、综合并发症指数和腹水量。
由于干预组的主要结局显示出具有统计学意义的结果,该研究在达到计算样本量之前提前终止。在92例患者中,36例门静脉压力升高,这与肝切除术后B级和C级肝衰竭发生率更高(41.67%对3.57%,P<.001)、腹水量增加(5340 mL对1055 mL,P<.001)以及更高的综合并发症指数(20.90对8.70,P<.001)相关。在随机分组的亚组中,与脾动脉结扎术前值和对照组相比,脾动脉结扎术显著降低了门静脉压力和门静脉压力-中心静脉压力梯度,并显著降低了肝切除术后B级和C级肝衰竭的发生率(16.67%对66.67%,P=.006)、综合并发症指数(8.70对20.90,P=.034)。脾动脉结扎被确定为降低肝切除术后肝衰竭的独立因素(调整后相对风险,0.29)。
脾动脉结扎术在降低肝切除术后门静脉压力高的患者肝切除术后肝衰竭发生率方面有效。